Achiko AG (SIX: ACHI.SW) is developing disruptive diagnostic solutions that puts people first. Invented by Dr Michael Edel, the company’s flagship product is a fast, friendly, affordable and accurate Covid-19 test with a companion app. The test and companion app were launched in Indonesia in mid-2021 and AptameX™ received the CE Mark in the European Union in May 2022. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX™ and companion health apps via its digital mobile health technology division, Teman Sehat™. The AptameX™ DNA aptamer tests can be rapidly chemically synthesised, are cost-effective and have wide potential across multiple disease diagnostics. Leveraging AptameX™ and Teman Sehat™, Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field. Headquartered in Zurich, Achiko has offices in Jakarta and Singapore.
| Website | http://www.achiko.com |
| Employees | 5 (2 on RocketReach) |
| Founded | 2018 |
| Industry | Biotechnology |
| Keywords | Covid 19 Testing, Diagnostic Solutions, Rapid Diagnostic Tests, Point Of Care Diagnostics, Medical Diagnostics, Infectious Disease Testing, Disease Detection, Diagnostic Tools, Testing Solutions, Molecular Diagnostics, Health Diagnostics, Healthcare Technology, Digital Health, Companion Diagnostics, Disruptive Technology, Medical Devices, Health Tech, At Home Testing, Affordable Healthcare, Accessible Healthcare |
| Competitors | Google, PayPal, Wise Solutions , Inc., Stripe, Square, Payoneer, Adyen, Venmo, Alipay, Skrill +45 more (view full list) |
Looking for a particular ACHIKO employee's phone or email?
Morris Berrie is the President of ACHIKO.
2 people are employed at ACHIKO.